NxStage Medical to Present at the JMP Securities Healthcare Conference on November 13, 2007
To listen to the audio web cast of the presentation during the event,please visit: http://www.nxstage.com and click on 'Investor Information'. Areplay will be available for 90 days immediately following the livepresentation.
About NxStage Medical
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company,headquartered in Lawrence, Massachusetts, USA, that develops, manufactures andmarkets innovative systems for the treatment of end-stage renal disease, orESRD, and acute kidney failure. For more information on NxStage and itsproducts, please visit the Company's website at www.nxstage.com.
This release contains "forward-looking statements" within the meaning ofthe Private Securities Litigation Reform Act of 1995. All statements containedin this release that are not clearly historical in nature are forward-looking,and the words "anticipate," "believe," "expect," "estimate," "plan," andsimilar expressions are generally intended to identify forward-lookingstatements. The forward-looking statements in this release include NxStage'splan to present at the JMP Securities Conference. Actual results may differmaterially from those indicated by these forward-looking statements as aresult of various important factors including, but not limited to, unexpecteddifficulty in getting to the conference and other factors that are discussedin NxStage's filings with the Securities and Exchange Commission, includingthe Quarterly Report on Form 10-Q for the quarter ended September 30, 2007.NxStage is under no obligation to (and expressly disclaims any such obligationto) update or alter its forward-looking statements, whether as a result of newinformation, future events or otherwise.
SOURCE NxStage Medical, Inc.
You May Also Like